![Heather Medwick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Heather Medwick
Director de Operaciones en CYTOPHAGE TECHNOLOGIES LTD. .
Fortuna: 161 550 $ al 31/05/2024
Cargos activos de Heather Medwick
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CYTOPHAGE TECHNOLOGIES LTD. | Director de Operaciones | - | - |
Presidente | 08/02/2024 | - | |
Secretario Corporativo | 08/02/2024 | - |
Historial de carrera de Heather Medwick
Antiguos cargos conocidos de Heather Medwick.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cytophage Technologies, Inc. (Old)
![]() Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Cytophage Technologies, Inc. is a Canadian biotech company that produces bacteriophages, which are organisms that infect and kill bacterial cells. Cytophage is based in Winnipeg, Canada, and Steven Theriault has been the CEO of the private company since 2017. The company's tailor-made bacteriophages are inexpensive, quick to produce, harmless to humans and animals, better for the environment, and highly effective against exposed bacteria. The company is working on a phage nasal spray that goes directly to the area where the SARS-CoV-2 virus infects the body, the mucosal membranes in the nose and throat, to promote the production of antibodies through an adaptive immune response, giving protection from infection. Cytophage's bacteriophages have countless applications in food safety, animal health, and human health, and can be used for the decontamination of hospital surfaces and counters, tools and instruments, beds and curtains, and anywhere else bacterial contamination is a concern. | Presidente | 01/06/2018 | - |
Estadísticas
Internacional
Canadá | 3 |
Operativa
President | 2 |
Chief Operating Officer | 1 |
Corporate Secretary | 1 |
Sectorial
Health Technology | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CYTOPHAGE TECHNOLOGIES LTD. | Finance |
Empresas privadas | 1 |
---|---|
Cytophage Technologies, Inc. (Old)
![]() Cytophage Technologies, Inc. (Old) BiotechnologyHealth Technology Cytophage Technologies, Inc. is a Canadian biotech company that produces bacteriophages, which are organisms that infect and kill bacterial cells. Cytophage is based in Winnipeg, Canada, and Steven Theriault has been the CEO of the private company since 2017. The company's tailor-made bacteriophages are inexpensive, quick to produce, harmless to humans and animals, better for the environment, and highly effective against exposed bacteria. The company is working on a phage nasal spray that goes directly to the area where the SARS-CoV-2 virus infects the body, the mucosal membranes in the nose and throat, to promote the production of antibodies through an adaptive immune response, giving protection from infection. Cytophage's bacteriophages have countless applications in food safety, animal health, and human health, and can be used for the decontamination of hospital surfaces and counters, tools and instruments, beds and curtains, and anywhere else bacterial contamination is a concern. | Health Technology |
- Bolsa de valores
- Insiders
- Heather Medwick
- Experiencia